Ocular Therapeutix Inc
NASDAQ:OCUL
Ocular Therapeutix Inc
NASDAQ:OCUL
Price:
5.7 USD
-1.72%
Market Closed
Updated:
Jun 3, 2024
Ocular Therapeutix Inc
Depreciation & Amortization
|
Ocular Therapeutix Inc
Depreciation & Amortization Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Ocular Therapeutix Inc
NASDAQ:OCUL
|
Depreciation & Amortization
$3.4m
|
CAGR 3-Years
8%
|
CAGR 5-Years
8%
|
CAGR 10-Years
24%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Depreciation & Amortization
$7.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
6%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Depreciation & Amortization
$9.9B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
72%
|
CAGR 10-Years
31%
|
|
|
Pfizer Inc
NYSE:PFE
|
Depreciation & Amortization
$6.5B
|
CAGR 3-Years
11%
|
CAGR 5-Years
1%
|
CAGR 10-Years
1%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Depreciation & Amortization
$3.9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-6%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Depreciation & Amortization
$1.6B
|
CAGR 3-Years
4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
See Also
What is Ocular Therapeutix Inc's Depreciation & Amortization?
Depreciation & Amortization
3.4m
USD
3.4m
USD
Based on the financial report for Mar 31, 2024, Ocular Therapeutix Inc's Depreciation & Amortization amounts to 3.4m USD.
What is Ocular Therapeutix Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
24%
24%
Over the last year, the Depreciation & Amortization growth was 69%. The average annual Depreciation & Amortization growth rates for Ocular Therapeutix Inc have been 8% over the past three years , 8% over the past five years , and 24% over the past ten years .
You don't have any saved screeners yet
